儿童院外心脏骤停后预测脑死亡的预后工具多中心验证
本研究为回顾性队列研究,纳入2011至2021年间5个PICU收治的院外心脏骤停(OHCA)后存活至少24小时但因OHCA死亡的患儿,提取成人BDCA评分要素,验证其对脑死亡这一明确结局的区分能力。共282例符合标准,其中169例(59.9%)被正式宣布脑死亡,58例(20.6%)表现与脑死亡一致但在完成正式宣布前撤除生命支持治疗。≥12月龄患儿AUC为0.82 [95% CI 0.75, 0.90],与成人开发队列和验证队列的AUC 0.82 [0.77, 0.86]和0.81 [0.76, 0.86]相近;婴儿队列区分能力较差(AUC = 0.61)。作者认为BDCA评分在≥12月龄OHCA患儿中显示前景,可结合现有 multimodal 预后评估方法考虑使用。
要点
- BDCA评分在≥12月龄OHCA患儿中区分脑死亡的AUC为0.82 [95% CI 0.75, 0.90],与成人开发队列AUC 0.82 [0.77, 0.86]和验证队列AUC 0.81 [0.76, 0.86]相近。
- 婴儿(<12月龄)队列中BDCA评分区分能力较差,AUC = 0.61。
- 282例符合纳入标准的患儿中,169例(59.9%)被正式宣布脑死亡,58例(20.6%)表现与脑死亡一致但在完成正式宣布前撤除了生命支持治疗。
- 作者认为BDCA评分在≥12月龄OHCA患儿中显示前景,可结合现有 multimodal 预后评估方法考虑使用。
适用人群与场景
- 5个PICU收治的院外心脏骤停(OHCA)后存活至少24小时但因OHCA死亡的患儿,年龄范围包括<12月龄婴儿和≥12月龄儿童。
研究设计与关键结果
- 研究类型:回顾性队列研究,5个PICU参与,纳入2011至2021年间OHCA后存活至少24小时但因OHCA死亡的患儿,共识别389例,282例符合纳入标准。
- 主要结局:169例(59.9%)被正式宣布脑死亡;58例(20.6%)表现与脑死亡一致但在完成正式宣布前撤除生命支持治疗(WLST)。
- BDCA评分对脑死亡的区分能力:≥12月龄队列AUC为0.82 [95% CI 0.75, 0.90],与成人开发队列AUC 0.82 [0.77, 0.86]和验证队列AUC 0.81 [0.76, 0.86]相近;婴儿队列AUC = 0.61。
- 亚组分析计划包括:<12月龄 vs ≥12月龄、表现与脑死亡一致但WLST前未正式宣布者、按病因和骤停持续时间分层(摘要未报告这些亚组的具体结果数值)。
证据类型、等级与局限
- 证据类型:回顾性队列研究(多中心,5个PICU)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为BDCA评分在≥12月龄OHCA患儿中显示前景,可结合现有 multimodal 预后评估方法考虑使用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Out-of-hospital cardiac arrest (OHCA) in pediatric patients is associated with high rates of mortality and neurologic injury, with no definitive evidence-based method to predict outcomes available. A prognostic scoring tool for adults, The Brain Death After Cardiac Arrest (BDCA) score, was recently developed and validated. We aimed to validate this score in pediatric patients.
METHODS: Retrospective cohort study of pediatric patients admitted to 5 PICUs after OHCA between 2011 and 2021. We extracted BDCA score elements for those who survived at least 24 hours but died as a result of their OHCA. We assessed score discrimination for the definitive outcome of brain death. Subgroup analysis was performed for infants < 12mo versus children ≥ 12mo, those who likely had brain death but had withdrawal of life sustaining therapy (WLST) prior to declaration, and by etiology and duration of arrest.
RESULTS: 389 subjects were identified across 5 institutions, with 282 meeting inclusion criteria. 169 (59.9%) were formally declared brain dead; 58 (20.6%) had findings consistent with brain death but had withdrawal of life sustaining therapies prior to completion of formal declaration. Area under the receiver operating characteristic curve for the age ≥ 12mo cohort was 0.82 [95% CI 0.75, 0.90], which mirrored the adult subject AUCs of 0.82 [0.77, 0.86] and 0.81 [0.76, 0.86] in the development and validation cohorts. Scores demonstrated worse discrimination in the infant cohort (AUC = 0.61).
CONCLUSIONS: The BDCA score shows promise in children ≥ 12mo following OHCA and may be considered in conjunction with existing multimodal prognostication approaches.
参考来源
- Henry M, Filipp SL, Aydin EY, et al. Multicentric validation of a prognostic tool for predicting brain death following out-of-hospital cardiac arrest in children. Resuscitation. 2023. PMID: 36764571. doi:10.1016/j.resuscitation.2023.109727
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。